SAB BIO(SABSW)
MIAMI BEACH, FLBiotechnology
Focus: SAB BIO is a public biotechnology company developing a platform for fully human, polyclonal antibodies, currently focused on oncology applications. The company is in early-stage development with minimal commercial revenue and operates as a research-driven biotech entity.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
12+1 this month
Stable — net +1 jobs in 30d
6 added, 5 removed. Backfill posture.
Should You Work at SAB BIO?
AI assessmentSAB BIO is a high-risk, high-upside platform bet suitable only for biotech professionals comfortable with startup failure modes and motivated by equity potential and scientific pioneering.
Why Work Here
- Join a platform-technology company with 11 open roles across R&D, regulatory, and manufacturing, offering ground-floor opportunity to build capabilities in emerging antibody science.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$1M
Help build intelligence for SAB BIO
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.